Thousands of people with multiple sclerosis (MS) in England, Wales and Northern Ireland will be offered a new 10-minute injection that can help slow progression of the disease, NHS England says.
The medicine, called ocrelizumab, is normally given as an infusion through a vein - a process that can take up to four hours in hospital. The new way to give the drug will help free up patients' and doctors' time, health chiefs say.
Ocrelizumab (also known as ocrevus) which is given twice a year, targets a specific part of the immune system, helping to lessen the attack. It can be used for two forms of the disease - active relapsing MS and early primary progressive MS.
"Ocrelizumab is working well for me right now and making me hopeful for a better and healthier future, but to be able to have an injection would be much more convenient to me," she said.
Collection
[
|
...
]